CYP2A6 and lung cancer: Furthermore, the NMR (measured as the ratio of urinary total 3HC/COT), which captures more of the functional variation in CYP2A6 activity than currently identified genetic variants alone, as well as potential environmental variation, has also been associated with lung cancer risk in a prospective multi-ethnic cohort study [135].